文献リスト

1) Garnett S, Abrams P. The natural history of the overactive bladder and detrusor overactivity. A review of the evidence regarding the long-term outcome of the overactive bladder. J Urol. 2003; 169: 843-8

2) Coyne KS, Sexton CC, Irwin DE, et al. The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study. BJU Int. 2008; 101: 1388-95

3) Yoshimura N, Chancellor MB. Current and future pharmacological treatment for overactive bladder. J Urol. 2002; 168: 1897-913

4) Clemens JQ, Link CL, Eggers PW, et al; BACH Survey Investigators. Prevalence of painful bladder symptoms and effect on quality of life in black, Hispanic and white men and women. J Urol. 2007; 177: 1390-4

5) Rosenberg MT, Page S, Hazzard MA. Prevalence of interstitial cystitis in a primary care setting. Urology. 2007; 69(4 Suppl): 48-52

6) Yoshimuira N, Birder LA. Interstitial cystitis and related painful bladder syndromes: pathphysiology. In: Pasricha PJ, Willis WD, Gebhart GF, editors. Chronic Abdominal and Visceral Pain: Theory and Practice. New York: Informa Healthcare USA; 2007. p. 495-520. (Section V, Chapter33)

7) Yoshimura N, Kaiho Y, Miyazato M, et al. Therapeutic receptor targets for lower urinary tract dysfunction. Naunyn Schmiedebergs Arch Pharmacol. 2008; 377: 437-48

8) Lazzeri M, Beneforti P, Benaim G, et al. Intravesical capsaicin for treatment of severe bladder pain: a randomized placebo controlled study. J Urol. 1996; 156: 947-52

9) Yoshimura N, de Groat WC. Increased excitability of afferent neurons innervating rat urinary bladder following chronic bladder inflammation. J Neurosci. 1999; 19: 4644-53

10) Yoshimura N, de Groat WC. Neural control of the lower urinary tract. Int. J Urol. 1997; 4: 111-25

11) de Groat WC, Kawatani M, Hisamitsu T, et al. Mechanisms underlying the recovery of urinary bladder function following spinal cord injury. J Auton Nerv Syst. 1990; 30: Suppl: S71-7

12) Chancellor MB, de Groat WC. Intravesical capsaicin and resiniferatoxin therapy: spicing up the ways to treat the overactive bladder. J Urol. 1999; 162: 3-11

13) Yoshimura N. Bladder afferent pathway and spinal cord injury: possible mechanisms inducing hyperreflexia of the urinary bladder. Prog Neurobiol. 1999; 57: 583-606

14) Fall M, Lindstr MS, Mazieres L. A bladder-to-bladder cooling reflex in the cat. J Physiol. 1990; 427: 281-300

15) Geirsson G, Fall M, Lindstr MS. The ice-water test- a simple and valuable supplement to routine cystometry. Br J Urol. 1993; 71: 681-5

16) Hirayama A, Fujimoto K, Matsumoto Y, et al. Positive response to ice water test associated with high-grade bladder outlet obstruction in patients with benign prostatic hyperplasia. Urology. 2003; 62: 909-13

17) Hirayama A, Fujimoto K, Matsumoto Y, et al. Nocturia in men with lower urinary tract symptoms is associated with both nocturnal polyuria and detrusor overactivity with positive response to ice water test. Urology. 2005; 65: 1064-9

18) Apostolidis A, Popat R, Yiangou Y, et al. Decreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivity. J Urol. 2005; 174: 977-82

19) Brady CM, Apostolidis AN, Harper M, et al. Parallel changes in bladder suburothelial vanilloid receptor TRPV1 and pan-neuronal marker PGP9. 5 immunoreactivity in patients with neurogenic detrusor overactivity after intravesical resiniferatoxin treatment. BJU Int. 2004; 93: 770-6

20) Silva C, Ribeiro MJ, Cruz F. The effect of intravesical resiniferatoxin in patients with idiopathic detrusor instability suggests that involuntary detrusor contractions are triggered by C-fiber input. J Urol. 2002; 168: 575-9

21) Yokoyama T, Nozaki K, Fujita O, et al. Role of C afferent fibers and monitoring of intravesical resiniferatoxin therapy for patients with idiopathic detrusor overactivity. J Urol. 2004; 172: 596-600

22) Yoshimura N, Seki S, Chancellor MB, et al. Targeting afferent hyperexcitability for therapy of the painful bladder syndrome. Urology. 2002; 59 (Suppl 5A): 61-7

23) Johansson SL, Ogawa K, Fall M. The pathology of interstitial cystitis. In: Sant GR, editor. Interstitial Cystitis. Philadelphia: Lippincott-Raven; 1997. p. 143-51

24) Theoharides TC, Kempuraj D, Sant GR. Mast cell involvement in interstitial cystitis: a review of human and experimental evidence. Urology. 2001; 57(Suppl 6A): 47-55

25) Lazzeri M, Beneforti P, Spinelli M, et al. Barbagli G, Turini D. Intravesical resiniferatoxin for the treatment of hypersensitive disorder: a randomized placebo controlled study. J Urol. 2000; 164: 676-9

26) Cockayne DA, Hamilton SG, Zhu QM, et al. Ford APDW. Urinary bladder hyporeflexia and reduced pain-related behaviour in P2X(3)-deficient mice. Nature. 2000; 407: 1011-5

27) Vlaskovska M, Kasakov L, Rong W, et al. P2X3 knock-out mice reveal a major sensory role for urothelially released ATP. J Neurosci. 2001; 21: 5670-7

28) Birder L, Nakamura Y, Kiss S, et al. Altered urinary bladder function in mice lacking the vanilloid receptor TRPV1. Nat Neurosci. 2002; 5: 856-60

29) Charrua A, Cruz CD, Cruz F, et al. Transient receptor potential vanilloid subfamily 1 is essential for the generation of noxious bladder input and bladder overactivity in cystitis. J Urol. 2007; 177: 1537-41

30) Nishiguchi J, Hayashi Y, Chancellor MB, et al. Detrusor overactivity induced by intravesical application of adenosine 5'-triphosphate (ATP) under different delivery conditions in rats. Urology. 2005; 66: 1332-7

31) Masuda H, Kim J-H, Kihara K, et al. Inhibitory roles of peripheral nitrergic mechanisms in capsaicin-induced detrusor overactivity in the rat. BJU International. 2007; 100: 912-8

32) Andersson KE, Yoshida M. Antimuscarinics and the overactive detrusor--which is the main mechanism of action？ Eur Urol. 2003; 43: 1-5

33) Yoshida M, Inadome A, Masunaga K, et al. Effects of age and stretch on ATP release from isolated human bladder. J Urol. 2004; 171: 136A

34) Kim Y, Yoshimura N, Masuda H, et al. Antimuscarinic agents exhibit local inhibitory effects on muscarinic receptors in bladder-afferent pathways. Urology. 2005; 65: 238-42

35) Dang K, Bielefeldt K, Gebhart GF. Differential responses of bladder lumbosacral and thoracolumbar dorsal root ganglion neurons to purinergic agonists, protons, and capsaicin. J Neurosci. 2005; 25: 3973-84

36) de Groat WC, Yoshimura N. Pharmacology of the lower urinary tract. Ann Rev Pharmacol Toxicol. 2001; 41: 691-721

37) Sun Y, Chai TC. Up-regulation of P2X3 receptor during stretch of bladder urothelial cells from patients with interstitial cystitis. J Urol. 2004; 171: 448-52

38) Sun Y, Chai TC. Augmented extracellular ATP signaling in bladder urothelial cells from patients with interstitial cystitis. Am J Physiol Cell Physiol. 2006; 290: C27-34

39) Sun Y, Chai TC. Effects of dimethyl sulphoxide and heparin on stretch-activated ATP release by bladder urothelial cells from patients with interstitial cystitis. BJU Int. 2002; 90: 381-5

40) Birder LA, Barrick SR, Roppolo JR, et al. Feline interstitial cystitis results in mechanical hypersensitivity and altered ATP release from bladder urothelium. Am J Physiol Renal Physiol. 2003; 285: F423-9

41) Yoshimura N, Seki S, Erickson KA, et al. Histological and electrical properties of rat dorsal root ganglion neurons innervating the lower urinary tract. J Neurosci. 2003; 23: 4355-61

42) Cox PJ. Cyclophosphamide cystitis-identification of acrolein as the causative agent. Biochem Pharmacol. 1979; 28: 2045-9

43) Kirimoto T, Nakano K, Irimura K, et al. Beneficial effects of suplatast tosilate (IPD-1151T) in a rat cystitis model induced by intravesical hydrochloric acid. BJU Int. 2007; 100: 935-9

44) Lanteri-Minet M, Bon K, de Pommery J, et al. Cyclophosphamide cystitis as a model of visceral pain in rats: model elaboration and spinal structures involved as revealed by the expression of c-Fos and Krox-24 proteins. Exp Brain Res. 1995; 105: 220-32

45) Hayashi Y, Kirimoto T, Takimoto K, et al. Hyperexcitability of afferent neurons innervating the bladder is associated with reduction in Kv1. 4 channel expression in rats with chronic cystitis. J Urol. 2005; 173: 332

46) Dang K, Bielefeldt K, Gebhart GF. Gastric ulcers reduce A-type potassium currents in rat gastric sensory ganglion neurons. Am J Physiol Gastrointest Liver Physiol. 2004; 286: G573-9

47) Stewart T, Beyak MJ, Vanner S. Ileitis modulates potassium and sodium currents in guinea pig dorsal root ganglia sensory neurons. J Physiol (London). 2003; 552: 797-807

48) Sculptoreanu A, de Groat WC, Buffington CA, et al. Abnormal excitability in capsaicin-responsive DRG neurons from cats with feline interstitial cystitis. Exp Neurol. 2005; 193: 437-43

49) Hu VY, Zvara P, Dattilio A, et al. Decrease in bladder overactivity with REN1820 in rats with cyclophosphamide induced cystitis. J Urol. 2005; 173: 1016-21

50) Seki S, Sasaki K, Fraser MO, et al. Immunoneutralization of nerve growth factor in lumbosacral spinal cord reduces bladder hyperreflexia in spinal cord injured rats. J Urol. 2002; 168: 2269-74

51) Steers WD, Kolbeck S, Creedon D, et al. Nerve growth factor in the urinary bladder of the adult regulates neuronal form and function. J Clin Invest. 1991; 88: 1709-15

52) Vizzard MA. Changes in urinary bladder neurotrophic factor mRNA and NGF protein following urinary bladder dysfunction. Exp Neurol. 2000; 161: 273

53) Okragly AJ, Niles AL, Saban R, et al. Elevated tryptase, nerve growth factor, neurotrophin-3 and glial cell line-derived neurotrophic factor levels in the urine of interstitial cystitis and bladder cancer patients. J Urol. 1999; 161: 438-41

54) Lowe EM, Anand P, Terenghi G, et al. Increased nerve growth factor levels in the urinary bladder of women with idiopathic sensory urgency and interstitial cystitis. Br J Urol. 1997; 79: 572-7

55) Vizzard MA. Changes in urinary bladder neurotrophic factor mRNA and NGF protein following urinary bladder dysfunction. Exp Neurol. 2000; 161: 273

56) Qiao LY, Vizzard MA. Cystitis-induced upregulation of tyrosine kinase(TrkA, TrkB)receptor expression and phosphorylation in rat micturition pathways. J Comp Neurol. 2002; 454: 200-11

57) Lamb K, Gebhart GF, Bielefeldt K. Increased nerve growth factor expression triggers bladder overactivity. J Pain. 2004; 5: 150-6

58) Yoshimura N, Bennett NE, Hayashi Y, et al. Bladder overactivity and hyperexcitability of bladder afferent neurons following intrathecal delivery of nerve growth factor in rats. J Neurosci. 2006; 26: 10847-55

59) Zvara P, Vizzard MA. Exogenous overexpression of nerve growth factor in the urinary bladder produces bladder overactivity and altered micturition circuitry in the lumbosacral spinal cord. BMC Physiol. 2007; 7: 9

NPO医学中央雑誌刊行会 https://www.jamas.or.jp/ info@jamas.or.jp